Strategic partnerships The company has a strong and growing network of collaborations with multiple bioprocess and research suppliers (Acepix Biosciences, Vector Biolabs, AMSBIO, System Biosciences, EBOligos, TargetMol, Gamma Proteins). This indicates fertile ground for expanding product lines through co-marketing, bundled offerings, or exclusive distribution arrangements.

Wide product portfolio Partnerships span cell biology, molecular biology, regenerative medicine, histopathology, and viral vectors, suggesting opportunities to cross-sell reagents, kits, and specialized discovery libraries to an established customer base actively seeking breadth in research tools.

Growing revenue base With annual revenue in the hundred-million range and a large employee base, there is likely demand for scalable enterprise solutions, procurement integrations, and volume-based pricing, making it suitable for long-term contracts and ERP-friendly purchasing options.

Digital engagement The tech stack features popular web and analytics tools, indicating a modern, data-driven sales approach. Leverage website traffic, partner pages, and digital catalogs to tailor outreach, retargeting, and account-based marketing campaigns.

Public-facing alliances Frequent press releases on partnerships signal transparency and an openness to collaboration. This provides a channel for co-branded campaigns, sponsored content, and joint demonstrations to highlight new capabilities to researchers and procurement teams.